These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 1310742

  • 1. 2-[(2-pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A novel class of gastric H+/K(+)-ATPase inhibitors.
    Weidmann K, Herling AW, Lang HJ, Scheunemann KH, Rippel R, Nimmesgern H, Scholl T, Bickel M, Metzger H.
    J Med Chem; 1992 Feb 07; 35(3):438-50. PubMed ID: 1310742
    [Abstract] [Full Text] [Related]

  • 2. 2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors.
    Yamada M, Yura T, Morimoto M, Harada T, Yamada K, Honma Y, Kinoshita M, Sugiura M.
    J Med Chem; 1996 Jan 19; 39(2):596-604. PubMed ID: 8558532
    [Abstract] [Full Text] [Related]

  • 3. A substituted thieno[3.4-d]imidazole versus substituted benzimidazoles as H+, K+-ATPase inhibitors.
    Herling AW, Bickel M, Lang HJ, Weidmann K, Rösner M, Metzger H, Rippel R, Nimmesgern H, Scheunemann KH.
    Pharmacology; 1988 Jan 19; 36(5):289-97. PubMed ID: 2841691
    [Abstract] [Full Text] [Related]

  • 4. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole.
    Beil W, Staar U, Sewing KF.
    Eur J Pharmacol; 1990 Oct 23; 187(3):455-67. PubMed ID: 1963594
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationships of N-substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors.
    Yamakawa T, Matsukura H, Nomura Y, Yoshioka M, Masaki M, Igata H, Okabe S.
    Chem Pharm Bull (Tokyo); 1991 Jul 23; 39(7):1746-52. PubMed ID: 1663837
    [Abstract] [Full Text] [Related]

  • 6. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M, Saito N, Noto T, Tamaki H.
    J Pharmacol Exp Ther; 1996 Apr 23; 277(1):28-33. PubMed ID: 8613931
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM, Homerin M, Domagala F, Ficheux H, Sachs G.
    Biochem Pharmacol; 2006 Mar 14; 71(6):837-49. PubMed ID: 16405921
    [Abstract] [Full Text] [Related]

  • 8. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ, Buhr W, Brehm C, Palmer AM, Feth MP, Senn-Bilfinger J, Simon WA.
    Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5374-8. PubMed ID: 17723299
    [Abstract] [Full Text] [Related]

  • 9. Gastric acid inhibitory profile of saviprazole (HOE 731) compared to omeprazole.
    Herling AW, Scholl T, Bickel M, Lang HJ, Scheunemann KH, Weidmann K, Rippel R.
    Pharmacology; 1991 Oct 01; 43(6):293-303. PubMed ID: 1664524
    [Abstract] [Full Text] [Related]

  • 10. Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitors.
    Blass BE, Huang CT, Kawamoto RM, Li M, Liu S, Portlock DE, Rennells WM, Simmons M.
    Bioorg Med Chem Lett; 2000 Jul 17; 10(14):1543-5. PubMed ID: 10915046
    [Abstract] [Full Text] [Related]

  • 11. (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.
    Kohl B, Sturm E, Senn-Bilfinger J, Simon WA, Krüger U, Schaefer H, Rainer G, Figala V, Klemm K.
    J Med Chem; 1992 Mar 20; 35(6):1049-57. PubMed ID: 1313110
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P, Andersson K, Socrates T, Sidani S, Kosiek O, Geibel JP.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov 20; 291(5):G838-43. PubMed ID: 16798725
    [Abstract] [Full Text] [Related]

  • 13. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA, Herrmann M, Klein T, Shin JM, Huber R, Senn-Bilfinger J, Postius S.
    J Pharmacol Exp Ther; 2007 Jun 20; 321(3):866-74. PubMed ID: 17369284
    [Abstract] [Full Text] [Related]

  • 14. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
    Pope AJ, Boehm MK, Leach C, Ife RJ, Keeling D, Parsons ME.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1543-9. PubMed ID: 7503755
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide derivatives as a new class of gastric (H+/K+)-ATPase inhibitors II. Synthesis and structure-activity relationships of 2[(2,4-dimethoxybenzyl)sulfinyl]-N-(4-pyridinyl)pyridine-3-carboxamides.
    Terauchi H, Tanitame A, Tada K, Nakamura K, Seto Y, Nishikawa Y.
    Chem Pharm Bull (Tokyo); 1997 Jun 09; 45(6):1027-38. PubMed ID: 9214708
    [Abstract] [Full Text] [Related]

  • 16. 2-[[(4-Amino-2-pyridyl)methyl]sulfinyl]benzimidazole H+/K+-ATPase inhibitors. The relationship between pyridine basicity, stability, and activity.
    Ife RJ, Dyke CA, Keeling DJ, Meenan E, Meeson ML, Parsons ME, Price CA, Theobald CJ, Underwood AH.
    J Med Chem; 1989 Aug 09; 32(8):1970-7. PubMed ID: 2547073
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors. II.
    Yamakawa T, Matsukura H, Nomura Y, Yoshioka M, Masaki M, Harada H, Okabe S.
    Chem Pharm Bull (Tokyo); 1992 Mar 09; 40(3):675-82. PubMed ID: 1319287
    [Abstract] [Full Text] [Related]

  • 18. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
    Morii M, Takata H, Fujisaki H, Takeguchi N.
    Biochem Pharmacol; 1990 Feb 15; 39(4):661-7. PubMed ID: 2154989
    [Abstract] [Full Text] [Related]

  • 19. The inhibitory effect of HOE 731 in isolated rabbit gastric glands.
    Herling AW, Becht M, Lang HJ, Scheunemann KH, Weidmann K, Scholl T, Rippel R.
    Biochem Pharmacol; 1990 Oct 15; 40(8):1809-14. PubMed ID: 2173590
    [Abstract] [Full Text] [Related]

  • 20. Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
    Yenisehirli A, Onur R.
    Eur J Pharmacol; 2005 Sep 20; 519(3):259-66. PubMed ID: 16125697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.